668.08MMarket Cap-2045P/E (TTM)
1.805High1.630Low3.83MVolume1.630Open1.550Pre Close6.67MTurnover1.59%Turnover RatioLossP/E (Static)371.15MShares3.16052wk High1.31P/B433.31MFloat Cap1.21052wk Low--Dividend TTM240.73MShs Float49.455Historical High--Div YieldTTM11.29%Amplitude0.920Historical Low1.741Avg Price1Lot Size
Standard BioTools Stock Forum
assay services, kits and related revenue in 2024; and
-- Ended the quarter with cash, cash equivalents, restricted cash and
short-term investments of $464 million, after accounting for $71 million
cash payments for merger-related expenses, settlement of year-end
operating accruals, debt retirement and completed stock buybacks.
2 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE
Benzinga· 1 min ago
No comment yet